Delayed Treatment with Hypothermia Protects Against the No-reflow Phenomenon Despite Failure to Reduce Infarct Size

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2013 Mar 26

PMID 23525431

Citations 21

Authors

Sharon L Hale

Michael J Herring

Robert A Kloner

Affiliations

Soon will be listed here.

Abstract

Background: Many studies have shown that when hypothermia is started after coronary artery reperfusion (CAR), it is ineffective at reducing necrosis. However, some suggest that hypothermia may preferentially reduce no-reflow. Our aim was to test the effects of hypothermia on no-reflow when initiated close to reperfusion and 30 minutes after reperfusion, times not associated with a protective effect on myocardial infarct size.

Methods And Results: Rabbits received 30 minutes coronary artery occlusion/3 hours CAR. In protocol 1, hearts were treated for 1 hour with topical hypothermia (myocardial temperature ≈32°C) initiated at 5 minutes before or 5 minutes after CAR, and the results were compared with a normothermic group. In protocol 2, hypothermia was delayed until 30 minutes after CAR and control hearts remained normothermic. In protocol 1, risk zones were similar and infarct size was not significantly reduced by hypothermia initiated close to CAR. However, the no-reflow defect was significantly reduced by 43% (5 minutes before CAR) and 38% (5 minutes after CAR) in hypothermic compared with normothermic hearts (P=0.004, ANOVA, P=ns between the 2 treated groups). In protocol 2, risk zones and infarct sizes were similar, but delayed hypothermia significantly reduced no-reflow in hypothermic hearts by 30% (55±6% of the necrotic region in hypothermia group versus 79±6% with normothermia, P=0.008).

Conclusion: These studies suggest that treatment with hypothermia reduces no-reflow even when initiated too late to reduce infarct size and that the microvasculature is especially receptive to the protective properties of hypothermia and confirm that microvascular damage is in large part a form of true reperfusion injury.

Citing Articles

Hypothermia for Cardioprotection in Acute Coronary Syndrome Patients: From Bench to Bedside.

Pyrpyris N, Dimitriadis K, Iliakis P, Theofilis P, Beneki E, Terentes-Printzios D J Clin Med. 2024; 13(18).

PMID: 39336877 PMC: 11432135. DOI: 10.3390/jcm13185390.

No-reflow after stroke reperfusion therapy: An emerging phenomenon to be explored.

Jia M, Jin F, Li S, Ren C, Ruchi M, Ding Y CNS Neurosci Ther. 2024; 30(2):e14631.

PMID: 38358074 PMC: 10867879. DOI: 10.1111/cns.14631.

Mechanisms of the "No-Reflow" Phenomenon After Acute Myocardial Infarction: Potential Role of Pericytes.

Kaul S, Methner C, Cao Z, Mishra A JACC Basic Transl Sci. 2023; 8(2):204-220.

PMID: 36908667 PMC: 9998747. DOI: 10.1016/j.jacbts.2022.06.008.

Dihydrotanshinone I preconditions myocardium against ischemic injury PKM2 glutathionylation sensitive to ROS.

Wu X, Liu L, Zheng Q, Ye H, Yang H, Hao H Acta Pharm Sin B. 2023; 13(1):113-127.

PMID: 36815040 PMC: 9939318. DOI: 10.1016/j.apsb.2022.07.006.

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.

Ferdinandy P, Andreadou I, Baxter G, Botker H, Davidson S, Dobrev D Pharmacol Rev. 2023; 75(1):159-216.

PMID: 36753049 PMC: 9832381. DOI: 10.1124/pharmrev.121.000348.

References

Hale S, Kloner R . Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit. J Cardiovasc Pharmacol Ther. 2010; 15(1):60-7. DOI: 10.1177/1074248409357742. View

Rezkalla S, Dharmashankar K, Abdalrahman I, Kloner R . No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol. 2010; 23(5):429-36. DOI: 10.1111/j.1540-8183.2010.00561.x. View

Ly H, Denault A, Dupuis J, Vadeboncoeur A, Harel F, Arsenault A . A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (the NICAMI Study). Am Heart J. 2005; 150(5):933. DOI: 10.1016/j.ahj.2005.02.049. View

Brosh D, Assali A, Mager A, Porter A, Hasdai D, Teplitsky I . Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol. 2007; 99(4):442-5. DOI: 10.1016/j.amjcard.2006.08.054. View

Bolognese L, Falsini G, Liistro F, Angioli P, Ducci K . Epicardial and microvascular reperfusion with primary percutaneous coronary intervention. Ital Heart J. 2005; 6(6):447-52. View

Morishima I, Sone T, Mokuno S, Taga S, Shimauchi A, Oki Y . Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty. Am Heart J. 1995; 130(2):239-43. DOI: 10.1016/0002-8703(95)90434-4. View

Gotberg M, Olivecrona G, Engblom H, Ugander M, van der Pals J, Heiberg E . Rapid short-duration hypothermia with cold saline and endovascular cooling before reperfusion reduces microvascular obstruction and myocardial infarct size. BMC Cardiovasc Disord. 2008; 8:7. PMC: 2323360. DOI: 10.1186/1471-2261-8-7. View

Schwarzl M, Huber S, Maechler H, Steendijk P, Seiler S, Truschnig-Wilders M . Left ventricular diastolic dysfunction during acute myocardial infarction: effect of mild hypothermia. Resuscitation. 2012; 83(12):1503-10. PMC: 3500695. DOI: 10.1016/j.resuscitation.2012.05.011. View

Dixon S, Whitbourn R, Dae M, Grube E, Sherman W, Schaer G . Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2002; 40(11):1928-34. DOI: 10.1016/s0735-1097(02)02567-6. View

10.

Joris I, DeGirolami U, Wortham K, Majno G . Vascular labelling with monastral blue B. Stain Technol. 1982; 57(3):177-83. DOI: 10.3109/10520298209066611. View

11.

Hale S, Dae M, Kloner R . Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction. Cardiovasc Res. 2003; 59(3):715-22. DOI: 10.1016/s0008-6363(03)00456-5. View

12.

Reffelmann T, Kloner R . Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol. 2002; 283(3):H1099-107. DOI: 10.1152/ajpheart.00270.2002. View

13.

Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H . Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000; 36(4):1202-9. DOI: 10.1016/s0735-1097(00)00865-2. View

14.

Keller E, Imhof H, Gasser S, Terzic A, Yonekawa Y . Endovascular cooling with heat exchange catheters: a new method to induce and maintain hypothermia. Intensive Care Med. 2003; 29(6):939-943. DOI: 10.1007/s00134-003-1685-3. View

15.

Hale S, Kloner R . Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia. Am J Physiol. 1997; 273(1 Pt 2):H220-7. DOI: 10.1152/ajpheart.1997.273.1.H220. View

16.

Jarrah S, Dziodzio J, Lord C, Fraser G, Lucas L, Riker R . Surface cooling after cardiac arrest: effectiveness, skin safety, and adverse events in routine clinical practice. Neurocrit Care. 2011; 14(3):382-8. DOI: 10.1007/s12028-011-9506-y. View

17.

Zar H, Tanigawa K, Kim Y, Lancaster Jr J . Mild therapeutic hypothermia for postischemic vasoconstriction in the perfused rat liver. Anesthesiology. 1999; 90(4):1103-11. DOI: 10.1097/00000542-199904000-00025. View

18.

Hale S, Dave R, Kloner R . Regional hypothermia reduces myocardial necrosis even when instituted after the onset of ischemia. Basic Res Cardiol. 1998; 92(5):351-7. DOI: 10.1007/BF00788947. View

19.

Duncker D, Klassen C, Ishibashi Y, Herrlinger S, Pavek T, BACHE R . Effect of temperature on myocardial infarction in swine. Am J Physiol. 1996; 270(4 Pt 2):H1189-99. DOI: 10.1152/ajpheart.1996.270.4.H1189. View

20.

Orn S, Manhenke C, Greve O, Larsen A, Bonarjee V, Edvardsen T . Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J. 2009; 30(16):1978-85. DOI: 10.1093/eurheartj/ehp219. View